Yes, Repatha (evolocumab) is classified as a specialty drug by insurers and pharmacy benefit managers. This designation affects how you get the medication, what you pay, and which pharmacy fills your prescription. Repatha checks several boxes that define specialty medications: it’s a high-cost injectable that requires refrigeration, prior authorization, and ongoing clinical monitoring.
Why Repatha Is Classified as Specialty
Specialty drugs are distinguished from everyday prescriptions by a combination of factors: high cost, complex storage or administration, and the need for closer clinical oversight. Repatha hits all three. It’s a self-injected biologic that must be stored in a refrigerator between 36°F and 46°F, cannot be frozen or shaken, and needs to be kept in its original carton to protect it from light. If left at room temperature (68°F to 77°F), it’s only good for 30 days before it must be thrown away.
Repatha is also expensive. The current U.S. list price runs roughly $600 per month, though Amgen recently launched a direct-to-patient program called AmgenNow offering it at $239 per month, nearly 60% below list price. Even at the reduced price, it far exceeds what most retail prescriptions cost.
How It Works and Who Takes It
Repatha belongs to a class of drugs called PCSK9 inhibitors. Your liver has receptors on its surface that grab LDL cholesterol from the bloodstream and pull it in for disposal. A protein called PCSK9 breaks down those receptors, reducing your liver’s ability to clear LDL. Repatha blocks PCSK9, so more of those receptors stay active and your liver removes LDL cholesterol more efficiently.
It’s prescribed for people with familial hypercholesterolemia (a genetic condition causing very high cholesterol) or established cardiovascular disease who haven’t reached their cholesterol goals with statins alone. Most patients inject it under the skin every two weeks, or take a larger dose once a month. The monthly dose can be given with a single on-body infusor that delivers the medication over about five minutes, or as three separate injections given within 30 minutes using prefilled autoinjectors.
What Specialty Designation Means for You
The practical impact of the specialty label shows up at the pharmacy counter. Your insurance plan will likely require you to fill Repatha through a designated specialty pharmacy rather than your local drugstore. Specialty pharmacies operate differently from retail ones. They deliver medications to your door in insulated, temperature-controlled containers with tracking. They also provide services you won’t get at a retail counter: clinical reviews by pharmacists trained in your specific condition, coordination with your doctor’s office, help navigating insurance approvals, and access to financial assistance programs.
You typically don’t get to choose which specialty pharmacy fills your prescription. Your insurance plan dictates that. In some cases a retail pharmacy can order and dispense a specialty medication, but this is the exception rather than the norm for drugs like Repatha.
Prior Authorization Requirements
Nearly every insurer requires prior authorization before covering Repatha, and the criteria can be extensive. At a minimum, most plans require that you’re already taking a statin (or have documented statin intolerance or a medical reason you can’t take one). Many commercial and government plans also require that you’ve tried additional cholesterol-lowering medications before approving a PCSK9 inhibitor.
LDL cholesterol levels are the most common clinical benchmark insurers use. Required thresholds vary widely depending on your diagnosis and your plan. For people with cardiovascular disease, some plans set the bar at an LDL above 70; others won’t approve until LDL exceeds 130. For familial hypercholesterolemia, the range is even broader, from 100 to 190 for the heterozygous form and 100 to 500 for the homozygous form. If you have familial hypercholesterolemia, many plans also require documentation confirming the diagnosis, sometimes including genetic testing or meeting specific clinical diagnostic criteria.
Getting approved isn’t the end of the paperwork. A significant number of plans require proof that Repatha is actually lowering your LDL before they’ll continue covering it. Over a third of commercial and government plans also require documentation that you’re taking the medication consistently, often defined as filling your prescriptions at least 80% of the time.
Monitoring While on Repatha
Your doctor will check your LDL cholesterol periodically to confirm the drug is working. The cholesterol-lowering effect can be measured as early as four weeks after starting treatment. One detail worth knowing: if you’re on the once-monthly dosing schedule, your LDL levels can fluctuate during the month. The most accurate reading comes from a blood draw just before your next scheduled dose, when levels are at their highest point in the cycle.
Reducing Your Out-of-Pocket Cost
Specialty drug copays can be steep, sometimes hundreds of dollars per fill. Several paths exist to bring that number down. Amgen’s direct-to-patient program prices Repatha at $239 per month without going through insurance. For patients with government insurance (Medicare, Medicaid, or TRICARE), the PAN Foundation offers copay grants of $1,900 initially, with up to $3,800 available per year for those whose household income falls at or below 400% of the federal poverty level. If you exhaust the initial grant, you can apply for additional funding within the same eligibility period as long as the fund is open.
Specialty pharmacies themselves often have staff dedicated to helping patients find and apply for these programs. If you’re struggling with cost, your specialty pharmacy is a reasonable first call, since they deal with financial assistance navigation routinely.